Arcis Biotechnology Limited
The Innovation Centre, Sci-tech Daresbury
About Arcis Biotechnology LimitedArcis Biotechnology Ltd., a research and development company, specializes in producing a range of surface protection technologies. It develops a surface protection technology that is designed to kill a spectrum of micro-organisms, including bacteria, virus, germinating spores, fungi, mould, algae, and moss.
CEO: Peter Whitehurst
CSO: Jan Rogers
10 articles with Arcis Biotechnology Limited
7/26/2019Biotech and pharma companies bolster their executive leadership and boards of directors with this week's appointments.
Arcis Biotechnology, the nucleic acid sample preparation solution provider, announced it has appointed Professor Steve Howell as Non-Executive Chairman of its Board of Directors.
7/18/2019Pharma and biotech companies from across the globe provide updates on their pipelines and corporate strategy.
Arcis Biotechnology and Mirnax Biosens Sign Exclusive License Agreement for Arcis Sample Prep Technology
Enables stabilisation of microRNA biomarkers for early disease diagnosis
Providing researchers with an automated solution for two-step nucleic acid sample preparation
Andrew Alliance Announces Co-marketing Agreement With Arcis Biotechnology to Offer Hands-free Nucleic Acid Stabilization and Preparation
Andrew Alliance and Arcis Biotechnology today announced a co-marketing relationship for deploying protocols that automate sample preparation for nucleic acid analysis on Andrew Alliance platforms.
Agreement gives Teleflex access to Arcis’ nucleic acid sample preparation technology
Arcis Biotechnology Raises £1.25 Million (USD $1.63 Million) Funding and Opens Further £0.5 Million Investment Opportunity Through Capital Cell
£1.25 million already secured based on pre-money valuation of £18.2 million